First Time Loading...

SHL Telemedicine Ltd
SIX:SHLTN

Watchlist Manager
SHL Telemedicine Ltd Logo
SHL Telemedicine Ltd
SIX:SHLTN
Watchlist
Price: 4.75 CHF -2.06% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

SHLTN Price Targets Summary
SHL Telemedicine Ltd

Wall Street analysts forecast SHLTN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHLTN is 10.5 CHF .

SHLTN Lowest Forecast
Wall Street Target
Not Available
SHLTN Average Forecast
Wall Street Target
10.5 CHF
121% Upside
SHLTN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
10.5 CHF
121% Upside
Highest
Price Target
Not Available
SHL Telemedicine Ltd Competitors:
Price Targets
600763
Topchoice Medical Co Inc
60% Upside
VMD
Viemed Healthcare Inc
78% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
8% Downside
K
KLINIQ
Klinique Medical Clinic PCL
19% Upside
600763
Topchoice Medical Co Inc
60% Upside
VMD
Viemed Healthcare Inc
78% Upside
VIJAYA
Vijaya Diagnostic Centre Ltd
8% Downside
K
KLINIQ
Klinique Medical Clinic PCL
19% Upside
T
5G3
Talkmed Group Ltd
59% Upside
H
AIDX
Healwell Al Inc
11% Downside
HIMS
Hims & Hers Health Inc
28% Upside
A
9860
Adicon Holdings Ltd
53% Upside

Revenue
Forecast

Revenue Estimate
SHL Telemedicine Ltd

For the last 8 years the compound annual growth rate for SHL Telemedicine Ltd's revenue is 5%. The projected CAGR for the next 6 years is 1%.

5%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
SHL Telemedicine Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
SHL Telemedicine Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
SHLTN intrinsic value, competitors valuation, and company profile.
DCF Valuation
SHLTN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SHLTN stock valuation using valuation multiples.
Wall Street Estimates
SHLTN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SHLTN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SHLTN's stock price target?
Price Target
10.5 CHF

According to Wall Street analysts, the average 1-year price target for SHLTN is 10.5 CHF .

What is SHL Telemedicine Ltd's Revenue forecast?
Projected CAGR
1%

For the last 8 years the compound annual growth rate for SHL Telemedicine Ltd's revenue is 5%. The projected CAGR for the next 6 years is 1%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.